2007
DOI: 10.1007/s12033-007-0037-x
|View full text |Cite
|
Sign up to set email alerts
|

Chemical genomics: a challenge for de novo drug design

Abstract: De novo design provides an in silico toolkit for the design of novel small molecular structures to a set of specified structural constraints. With the avalanche of bioinformatics data, de novo design is ideally suited for exploring molecules that could be useful for chemical genomics. The design process involves manipulation of the input, modification of structural constraints, and further processing of the de novo generated molecules using various modular toolkits. The development of a theoretical framework f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…Molecules-In this study, a preconstituted library, composed of bicyclic peptidomimetics, bicycles from tartaric acid and amino acids (BTAa), 3 was used for assays on selected yeast strains (supplemental Table 1 First Level Assays-First level assays allowed the selection of a restricted number of active molecules. W303 and 0117 strains were grown in YPD.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Molecules-In this study, a preconstituted library, composed of bicyclic peptidomimetics, bicycles from tartaric acid and amino acids (BTAa), 3 was used for assays on selected yeast strains (supplemental Table 1 First Level Assays-First level assays allowed the selection of a restricted number of active molecules. W303 and 0117 strains were grown in YPD.…”
Section: Methodsmentioning
confidence: 99%
“…New approaches emerging from chemical and biological knowledge, such as "chemical genetics" (2), consist of the study of biological systems by systematic investigation of the effects of small molecules on a specific cellular model rather than perturbing with gene mutations (3)(4)(5). This new approach has been divided into forward and reverse chemical genetics; the former is based on the research of a desired phenotypic effect following the administration of small molecules to biological systems of interest, whereas the latter is based on the investigation of the effects of small molecules against a specific target (6 -8).…”
mentioning
confidence: 99%
“…Thus, the issues raised through the interest in computational biology, bioinformatics and systems biology are translated into a more beneficial information involving a more complicated task of data interpretation. Several wealthy nations have divided their budgets allocating some portions of it to novel insights of pharmacogenomics since massive developments in genomic designs must be pushed through along with its trade value in the market [19] . The biotechnology field that follows the combined concepts of bioinformatics and genomics through the pharmaceutical product development of pharmacogenomics is crucial for the study of genomic function.…”
Section: Dissentmentioning
confidence: 99%
“…DNID approach is applied for designing where no inhibitors were reported previously [113,114]. In DNID, the ligand is built based upon the complementarity of the active site in a target with the ligand [115,116]. A webserver named "Drugster" has implemented LigBuilder for building ligands.…”
Section: Software Descriptionmentioning
confidence: 99%